CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $430,000 | -43.5% | 361,518 | -14.4% | 0.09% | -38.1% |
| Q2 2022 | $761,000 | -51.2% | 422,339 | -45.3% | 0.14% | -32.2% |
| Q1 2022 | $1,561,000 | -48.2% | 772,339 | -30.6% | 0.20% | -54.3% |
| Q4 2021 | $3,016,000 | -39.2% | 1,112,669 | 0.0% | 0.45% | +28.7% |
| Q3 2021 | $4,963,000 | -24.2% | 1,112,669 | -1.5% | 0.35% | -34.2% |
| Q2 2021 | $6,551,000 | +37.3% | 1,129,473 | +66.2% | 0.53% | +229.2% |
| Q1 2021 | $4,771,000 | -23.1% | 679,473 | -47.4% | 0.16% | -41.2% |
| Q4 2020 | $6,203,000 | -8.0% | 1,292,108 | +11.8% | 0.27% | -43.9% |
| Q3 2020 | $6,740,000 | +103.0% | 1,156,236 | +135.1% | 0.49% | +84.8% |
| Q2 2020 | $3,320,000 | -56.0% | 491,818 | -58.6% | 0.26% | -53.5% |
| Q1 2020 | $7,548,000 | +41.0% | 1,186,818 | +131.0% | 0.57% | -34.6% |
| Q4 2019 | $5,355,000 | – | 513,700 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |